Skin News and Research

RSS

$Bone loss alone fails to explain diabetes-related fracture risk$

Bone loss alone fails to explain diabetes-related fracture risk

A new study published in Diabetes Care finds that bone loss alone does not explain the increased fracture risk observed in some older adults with type 2 diabetes.

11 Aug 2026

New heart assembloid model mimics complex valve disorders

A multi-disciplinary, multi-institution group of researchers focused their expertise in genetics, mechanics, chemistry and biology on a chip the size of a postage stamp in order to model a particular class of heart conditions.

11 Aug 2026

New review urges proteostatic fitness standards for stem cell therapies

Stem cell therapies have expanded rapidly, with more than 115 clinical trials involving over 1,200 patients approved by late 2024. The U.S. Food and Drug Administration (FDA) recently approved Ryoncil (remestemcel‑L) for children with steroid‑refractory acute graft‑versus‑host disease, signaling a major shift toward routine clinical use.

11 Aug 2026

Novel transistor design improves precision in wearable electronic skin technology

The recent advancement of miniaturized and portable electronics, particularly wearable and flexible devices, has increased the demand for self-powered sensing technologies.

10 Aug 2026

Newly discovered protein pathway limits spinal cord injury damage

Spinal cord injury begins with immediate mechanical damage, but much of the lasting neurological loss develops during the secondary phase, when inflammation, oxidative stress and disrupted metabolism continue to injure surviving tissue.

10 Aug 2026

New drug delivers promising survival gains in pancreatic cancer

About 90% of people with pancreatic cancer have pancreatic ductal adenocarcinoma (PDAC), which is driven by an activating mutation in the KRAS gene.

9 Aug 2026

Human skin chemistry shapes species-specific mosquito attraction patterns

There is no such thing as a universal mosquito magnet. In a new study published in iScience, Florida International University (FIU) researchers pitted 119 human volunteers against three of the world's most dangerous mosquito species and found that not one person was attractive to all three.

7 Aug 2026

Multi-omics research uncovers new therapeutic targets for Fabry disease

A comprehensive review is shedding new light on Fabry disease, a rare inherited disorder that can progressively damage multiple organs and significantly affect quality of life.

6 Aug 2026

Wearable sensor technology detects physical patterns linked to mental distress

Researchers have shown that measurements taken from a person's fingertip could help identify physical patterns associated with stress, anxiety and depression.

6 Aug 2026

Scalable education program protects transplant survivors from elevated skin cancer risk

Experts at City of Hope, one of the nation's largest and most advanced cancer research and treatment organizations, are shining a spotlight on the risk of skin cancer faced by hematopoietic cell transplant (HCT) survivors, as well as the need for early detection.

6 Aug 2026

Researchers uncover mechanism linking skin inflammation to body-wide allergies

Our bodies experience allergic reactions when the immune system mistakenly overreacts to harmless substances, known as allergens, such as pollen, dust, or certain foods.

6 Aug 2026

Swiss flagship project harnesses AI and sensors for diabetes prevention

Type 2 diabetes generates high healthcare costs in Switzerland and causes significant suffering for those affected.

6 Aug 2026

Cortisol may distort the body signals that guide risky choices in men

In a randomized study of 109 young adults, researchers measured cortisol responses, skin conductance signals, and risk-taking during the Iowa Gambling Task after an acute psychosocial stressor. Cortisol reactivity altered how anticipatory bodily signals related to risky choices in men, although the stress condition did not increase overall risk-taking.

5 Aug 2026

Hypothyroidism linked to higher risk of obstructive sleep apnea

According to a study conducted in Brazil by researchers at the Federal University of São Paulo (UNIFESP) with participants from the São Paulo Epidemiological Sleep Study (EPISONO 2018), people with hypothyroidism experience a higher frequency and severity of obstructive sleep apnea (OSA).

5 Aug 2026

Blocking ZFP36L2 protein may disrupt colorectal cancer metastatic growth

Digestion is hard on the cells that line the human gut, and they are constantly being shed and replaced. This renewal is driven by a population of tireless stem cells.

5 Aug 2026

Discovery may help develop new treatments for immunosuppressed skin cancer patients

Researchers at The University of Texas MD Anderson Cancer Center have discovered that immunosuppressed patients with non-melanoma skin cancer are not missing the key cancer-fighting immune cells found in immunocompetent patients, but those cells – known as macrophages – have lost the ability to communicate effectively.

5 Aug 2026

Versatile receptor protein plays critical role in regulating tissue repair

A comprehensive new review highlights the expanding importance of Lgr6, a member of the G protein-coupled receptor family, as a critical regulator of tissue homeostasis, injury repair, and disease development across multiple organ systems.

5 Aug 2026

People with eczema face higher risk of developing shingles

An analysis in JDDG: Journal der Deutschen Dermatologischen Gesellschaft found that people with eczema (also known as atopic dermatitis) face an elevated risk of developing shingles (or herpes zoster).

5 Aug 2026

Researchers call for stronger safety testing of lip cosmetics

New peer-reviewed publications find significant gaps in lip product regulation and safety testing, including reliance on inappropriate skin models and significant underestimation of usage and ingestion rates, leaving consumers exposed to potential risks.

4 Aug 2026

AI tool helps customize radiopharmaceutical therapy dosing

Radiopharmaceutical therapy (RPT) has made great strides over the last 50 years, having only recently received FDA approval to treat prostate cancer. But despite the progress-and billions of dollars of industry investments-one area that has lagged behind is dosing, which is still one-size-fits-all.

4 Aug 2026